Digital Therapeutics Dtx Market
Digital Therapeutics (DTx) Market Forecasts to 2030 - Global Analysis By Offering (Programs, Software/Platforms and Virtual Reality/Games), Revenue Modal (Outcome/Value based, Subscription and One time Purchase/Licensing), Sales Channel, Application and By Geography
According to Stratistics MRC, the Global Digital Therapeutics (DTx) Market is accounted for $10.99 billion in 2024 and is expected to reach $53.02 billion by 2030 growing at a CAGR of 30.0% during the forecast period. Digital therapeutics (DTx) are software-based interventions designed to prevent, manage, or treat medical conditions. Unlike traditional pharmaceuticals, DTx delivers therapeutic interventions through digital platforms such as mobile apps, wearables, or virtual reality. These interventions often leverage elements of cognitive behavioral therapy, mindfulness techniques, or personalized algorithms to address various health issues, including mental health disorders, chronic diseases, and substance abuse. DTx offers scalable, accessible, and cost-effective solutions, empowering individuals to take control of their health outside of traditional healthcare settings.
According to the 2022 report estimates published by the International Diabetes Federation (IDF) Diabetes Atlas, 62.0% of all new Type 1 Diabetes cases in 2022 were in people aged 20 years or older.
Market Dynamics:
Driver:
Rising healthcare costs
Rising healthcare costs serve as a major driver propelling the growth of the digital therapeutics (DTx) market. As traditional healthcare expenses continue to surge, there's a growing need for cost-effective and accessible solutions. DTx offers a promising alternative, leveraging technology to deliver evidence-based interventions for various medical conditions at a fraction of the cost of conventional treatments. With the potential to reduce healthcare expenditures through remote monitoring, personalized interventions, and improved patient outcomes, DTx are increasingly recognized as a vital component in the quest to curb escalating healthcare costs.
Restraint:
Data privacy and security concerns
Data privacy and security concerns in the digital therapeutics (DTx) market revolve around safeguarding sensitive patient information and ensuring the integrity of treatment data. With the collection and analysis of personal health data, there's a heightened risk of breaches, leading to potential exploitation or identity theft. Moreover, maintaining confidentiality is crucial to building trust between patients and DTx providers. Security measures must be robust to prevent unauthorized access, tampering, or leaks of health data, ensuring compliance with regulations like HIPAA (Health Insurance Portability and Accountability Act) in the U.S. and GDPR (General Data Protection Regulation) in the European Union.
Opportunity:
Integration with wearable devices and sensors
Integration with wearable devices and sensors presents a significant opportunity in the digital therapeutics (DTx) market by enhancing real-time monitoring and personalized treatment delivery. By connecting with wearables like smartwatches and fitness trackers, DTx platforms can gather continuous biometric data, enabling more accurate health insights and treatment adjustments. This integration facilitates remote patient monitoring, allowing healthcare providers to intervene proactively and tailor interventions to individual patients needs. Wearable integration promotes patient engagement and adherence by offering a seamless user experience and real-time feedback.
Threat:
Health inequities and access
The emergence of digital therapeutics (DTx) holds promise for revolutionizing healthcare delivery by offering convenient, accessible, and personalized treatments. However, there's a looming concern regarding health inequities and access within this burgeoning market. While DTx has the potential to reach a wide audience, including underserved communities, disparities may arise due to factors like technological literacy, access to smartphones or internet connectivity, and socioeconomic status.
Covid-19 Impact:
The COVID-19 pandemic has significantly accelerated the adoption of digital therapeutics (DTx) as people seek remote healthcare solutions. With lockdowns and social distancing measures in place, there was a surge in demand for virtual healthcare services, including digital therapeutics. The pandemic highlighted the need for accessible and convenient healthcare options, leading to increased investment and innovation in the DTX market. Telemedicine platforms integrating digital therapeutics saw a rapid uptake, offering personalized treatment plans for chronic conditions like diabetes, mental health disorders, and hypertension.
The software/platforms segment is expected to be the largest during the forecast period
The software/platforms segment in the digital therapeutics (DTx) market has experienced robust growth due to several key factors. The increasing adoption of digital health solutions and wearable devices has propelled demand for software platforms that facilitate the delivery of DTx interventions. Additionally, advancements in technology, such as artificial intelligence and machine learning algorithms, have enabled the development of more sophisticated and personalized digital therapeutic solutions. Furthermore, the emphasis on preventive healthcare and the rising prevalence of chronic diseases have fueled the demand for digital therapeutics.
The treatment/care-related applications segment is expected to have the highest CAGR during the forecast period
The Treatment/Care-related Applications segment in the Digital Therapeutics (DTx) market has witnessed substantial growth due to the increasing prevalence of chronic diseases like diabetes, hypertension, and obesity has amplified the demand for remote monitoring and management solutions, which this segment provides. Advancements in technology, particularly in wearables and mobile health apps, have made it easier to track patient progress and deliver personalized interventions. Additionally, the rising adoption of telemedicine and virtual care models has further propelled the expansion of treatment- and care-related DTx applications.
Region with largest share:
The growth of the laser processing market in North America can be attributed to several key factors. Technological advancements have led to the development of more efficient and precise laser processing systems, increasing their adoption across various industries, including automotive, electronics, and healthcare. The region's robust manufacturing sector, particularly in the United States, has fueled demand for laser processing solutions for applications such as cutting, welding, and marking. Additionally, the rising emphasis on automation and productivity enhancement in industries has further propelled the uptake of laser processing technologies. Moreover, increasing investments in research and development activities aimed at enhancing laser processing capabilities have also contributed to market growth in the region.
Region with highest CAGR:
The Asia-Pacific region's laser processing market has witnessed substantial growth due to several factors. The region's burgeoning manufacturing sector, particularly in countries like China, Japan, and South Korea, has driven the demand for laser processing technologies across various industries such as automotive, electronics, and healthcare. Additionally, advancements in laser technology, including improved precision and efficiency, have fuelled adoption rates. Increasing investments in research and development by key market players and government initiatives promoting technological innovation have further propelled market expansion.
Key players in the market
Some of the key players in Digital Therapeutics (DTx) market include Akili Interactive Labs, Biofourmis, Inc., Brain+ A/S, CureApp, Inc., DarioHealth, Fitbit Health Solutions, Gaia AG, Lark Health, LifeScan, Inc., Omada Health Inc, Otsuka Holdings Co., Ltd., Pear Therapeutics Inc, ResMed, Teladoc Health, Virta Health Corp and WellDoc, Inc.
Key Developments:
In June 2024, Google recently introduced Fitbit Ace LTE — ""a new, first-of-its-kind connected smartwatch for kids ages 7+. Ace LTE transforms exercise into play, while also giving families peace of mind with reliable calling, messaging and location sharing with parents."" The company's VP of Product, Anil Sabharwal, said in a blog post.
In March 2024, Digital health company Welldoc has secured CE mark certification for its BlueStar mobile app, unlocking the advancement of its solutions in Europe. The app has been certified as a Class IIa medical device under the EU Medical Device Regulation.
Offerings Covered:
• Programs
• Software/Platforms
• Virtual Reality/Games
Revenue Modals Covered:
• Outcome/Value based
• Subscription
• One time Purchase/Licensing
Sales Channels Covered:
• Business to Customer
• Business to Business
Applications Covered:
• Preventive Applications
• Treatment/Care-related Applications
Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o UK
o Italy
o France
o Spain
o Rest of Europe
• Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o South Korea
o Rest of Asia Pacific
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Rest of Middle East & Africa
What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2022, 2023, 2024, 2026, and 2030
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances
Table of Contents
1 Executive Summary
2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Application Analysis
3.7 Emerging Markets
3.8 Impact of Covid-19
4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global Digital Therapeutics (DTx) Market, By Offering
5.1 Introduction
5.2 Programs
5.3 Software/Platforms
5.4 Virtual Reality/Games
6 Global Digital Therapeutics (DTx) Market, By Revenue Modal
6.1 Introduction
6.2 Outcome/Value based
6.3 Subscription
6.4 One time Purchase/Licensing
7 Global Digital Therapeutics (DTx) Market, By Sales Channel
7.1 Introduction
7.2 Business to Customer
7.2.1 Patients
7.2.2 Caregivers
7.3 Business to Business
7.3.1 Payers
7.3.2 Employers
7.3.3 Pharmaceutical Companies
7.3.4 Providers
8 Global Digital Therapeutics (DTx) Market, By Application
8.1 Introduction
8.2 Preventive Applications
8.2.1 Prediabetes
8.2.2 Obesity
8.2.3 Nutrition
8.2.4 Lifestyle Management
8.2.5 Other Preventive Applications
8.3 Treatment/Care-related Applications
8.3.1 Diabetes
8.3.2 Central nervous system Disorders
8.3.3 Mental Health Disorder
8.3.4 Chronic Respiratory Disorders
8.3.5 Musculoskeletal Disorders
8.3.6 Cardiovascular Diseases
8.3.7 Smoking Cessation
8.3.8 Medication Adherence
8.3.9 Gastrointestinal Disorders
8.3.10 Substance Use & Addiction Management
8.3.11 Rehabilitation & Patient Care
8.3.12 Insomnia
8.3.13 Hypertension
8.3.14 Other Treatment/Care-related Applications
9 Global Digital Therapeutics (DTx) Market, By Geography
9.1 Introduction
9.2 North America
9.2.1 US
9.2.2 Canada
9.2.3 Mexico
9.3 Europe
9.3.1 Germany
9.3.2 UK
9.3.3 Italy
9.3.4 France
9.3.5 Spain
9.3.6 Rest of Europe
9.4 Asia Pacific
9.4.1 Japan
9.4.2 China
9.4.3 India
9.4.4 Australia
9.4.5 New Zealand
9.4.6 South Korea
9.4.7 Rest of Asia Pacific
9.5 South America
9.5.1 Argentina
9.5.2 Brazil
9.5.3 Chile
9.5.4 Rest of South America
9.6 Middle East & Africa
9.6.1 Saudi Arabia
9.6.2 UAE
9.6.3 Qatar
9.6.4 South Africa
9.6.5 Rest of Middle East & Africa
10 Key Developments
10.1 Agreements, Partnerships, Collaborations and Joint Ventures
10.2 Acquisitions & Mergers
10.3 New Product Launch
10.4 Expansions
10.5 Other Key Strategies
11 Company Profiling
11.1 Akili Interactive Labs
11.2 Biofourmis, Inc.
11.3 Brain+ A/S
11.4 CureApp, Inc.
11.5 DarioHealth
11.6 Fitbit Health Solutions
11.7 Gaia AG
11.8 Lark Health
11.9 LifeScan, Inc.
11.10 Omada Health Inc
11.11 Otsuka Holdings Co., Ltd.
11.12 Pear Therapeutics Inc
11.13 ResMed
11.14 Teladoc Health
11.15 Virta Health Corp
11.16 WellDoc, Inc.
List of Tables
1 Global Digital Therapeutics (DTx) Market Outlook, By Region (2022-2030) ($MN)
2 Global Digital Therapeutics (DTx) Market Outlook, By Offering (2022-2030) ($MN)
3 Global Digital Therapeutics (DTx) Market Outlook, By Programs (2022-2030) ($MN)
4 Global Digital Therapeutics (DTx) Market Outlook, By Software/Platforms (2022-2030) ($MN)
5 Global Digital Therapeutics (DTx) Market Outlook, By Virtual Reality/Games (2022-2030) ($MN)
6 Global Digital Therapeutics (DTx) Market Outlook, By Revenue Modal (2022-2030) ($MN)
7 Global Digital Therapeutics (DTx) Market Outlook, By Outcome/Value based (2022-2030) ($MN)
8 Global Digital Therapeutics (DTx) Market Outlook, By Subscription (2022-2030) ($MN)
9 Global Digital Therapeutics (DTx) Market Outlook, By One time Purchase/Licensing (2022-2030) ($MN)
10 Global Digital Therapeutics (DTx) Market Outlook, By Sales Channel (2022-2030) ($MN)
11 Global Digital Therapeutics (DTx) Market Outlook, By Business to Customer (2022-2030) ($MN)
12 Global Digital Therapeutics (DTx) Market Outlook, By Patients (2022-2030) ($MN)
13 Global Digital Therapeutics (DTx) Market Outlook, By Caregivers (2022-2030) ($MN)
14 Global Digital Therapeutics (DTx) Market Outlook, By Business to Business (2022-2030) ($MN)
15 Global Digital Therapeutics (DTx) Market Outlook, By Payers (2022-2030) ($MN)
16 Global Digital Therapeutics (DTx) Market Outlook, By Employers (2022-2030) ($MN)
17 Global Digital Therapeutics (DTx) Market Outlook, By Pharmaceutical Companies (2022-2030) ($MN)
18 Global Digital Therapeutics (DTx) Market Outlook, By Providers (2022-2030) ($MN)
19 Global Digital Therapeutics (DTx) Market Outlook, By Application (2022-2030) ($MN)
20 Global Digital Therapeutics (DTx) Market Outlook, By Preventive Applications (2022-2030) ($MN)
21 Global Digital Therapeutics (DTx) Market Outlook, By Prediabetes (2022-2030) ($MN)
22 Global Digital Therapeutics (DTx) Market Outlook, By Obesity (2022-2030) ($MN)
23 Global Digital Therapeutics (DTx) Market Outlook, By Nutrition (2022-2030) ($MN)
24 Global Digital Therapeutics (DTx) Market Outlook, By Lifestyle Management (2022-2030) ($MN)
25 Global Digital Therapeutics (DTx) Market Outlook, By Other Preventive Applications (2022-2030) ($MN)
26 Global Digital Therapeutics (DTx) Market Outlook, By Treatment/Care-related Applications (2022-2030) ($MN)
27 Global Digital Therapeutics (DTx) Market Outlook, By Diabetes (2022-2030) ($MN)
28 Global Digital Therapeutics (DTx) Market Outlook, By Central nervous system Disorders (2022-2030) ($MN)
29 Global Digital Therapeutics (DTx) Market Outlook, By Mental Health Disorder (2022-2030) ($MN)
30 Global Digital Therapeutics (DTx) Market Outlook, By Chronic Respiratory Disorders (2022-2030) ($MN)
31 Global Digital Therapeutics (DTx) Market Outlook, By Musculoskeletal Disorders (2022-2030) ($MN)
32 Global Digital Therapeutics (DTx) Market Outlook, By Cardiovascular Diseases (2022-2030) ($MN)
33 Global Digital Therapeutics (DTx) Market Outlook, By Smoking Cessation (2022-2030) ($MN)
34 Global Digital Therapeutics (DTx) Market Outlook, By Medication Adherence (2022-2030) ($MN)
35 Global Digital Therapeutics (DTx) Market Outlook, By Gastrointestinal Disorders (2022-2030) ($MN)
36 Global Digital Therapeutics (DTx) Market Outlook, By Substance Use & Addiction Management (2022-2030) ($MN)
37 Global Digital Therapeutics (DTx) Market Outlook, By Rehabilitation & Patient Care (2022-2030) ($MN)
38 Global Digital Therapeutics (DTx) Market Outlook, By Insomnia (2022-2030) ($MN)
39 Global Digital Therapeutics (DTx) Market Outlook, By Hypertension (2022-2030) ($MN)
40 Global Digital Therapeutics (DTx) Market Outlook, By Other Treatment/Care-related Applications (2022-2030) ($MN)
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.
List of Figures
RESEARCH METHODOLOGY
We at ‘Stratistics’ opt for an extensive research approach which involves data mining, data validation, and data analysis. The various research sources include in-house repository, secondary research, competitor’s sources, social media research, client internal data, and primary research.
Our team of analysts prefers the most reliable and authenticated data sources in order to perform the comprehensive literature search. With access to most of the authenticated data bases our team highly considers the best mix of information through various sources to obtain extensive and accurate analysis.
Each report takes an average time of a month and a team of 4 industry analysts. The time may vary depending on the scope and data availability of the desired market report. The various parameters used in the market assessment are standardized in order to enhance the data accuracy.
Data Mining
The data is collected from several authenticated, reliable, paid and unpaid sources and is filtered depending on the scope & objective of the research. Our reports repository acts as an added advantage in this procedure. Data gathering from the raw material suppliers, distributors and the manufacturers is performed on a regular basis, this helps in the comprehensive understanding of the products value chain. Apart from the above mentioned sources the data is also collected from the industry consultants to ensure the objective of the study is in the right direction.
Market trends such as technological advancements, regulatory affairs, market dynamics (Drivers, Restraints, Opportunities and Challenges) are obtained from scientific journals, market related national & international associations and organizations.
Data Analysis
From the data that is collected depending on the scope & objective of the research the data is subjected for the analysis. The critical steps that we follow for the data analysis include:
- Product Lifecycle Analysis
- Competitor analysis
- Risk analysis
- Porters Analysis
- PESTEL Analysis
- SWOT Analysis
The data engineering is performed by the core industry experts considering both the Marketing Mix Modeling and the Demand Forecasting. The marketing mix modeling makes use of multiple-regression techniques to predict the optimal mix of marketing variables. Regression factor is based on a number of variables and how they relate to an outcome such as sales or profits.
Data Validation
The data validation is performed by the exhaustive primary research from the expert interviews. This includes telephonic interviews, focus groups, face to face interviews, and questionnaires to validate our research from all aspects. The industry experts we approach come from the leading firms, involved in the supply chain ranging from the suppliers, distributors to the manufacturers and consumers so as to ensure an unbiased analysis.
We are in touch with more than 15,000 industry experts with the right mix of consultants, CEO's, presidents, vice presidents, managers, experts from both supply side and demand side, executives and so on.
The data validation involves the primary research from the industry experts belonging to:
- Leading Companies
- Suppliers & Distributors
- Manufacturers
- Consumers
- Industry/Strategic Consultants
Apart from the data validation the primary research also helps in performing the fill gap research, i.e. providing solutions for the unmet needs of the research which helps in enhancing the reports quality.
For more details about research methodology, kindly write to us at info@strategymrc.com
Frequently Asked Questions
In case of any queries regarding this report, you can contact the customer service by filing the “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
Yes, the samples are available for all the published reports. You can request them by filling the “Request Sample” option available in this page.
Yes, you can request a sample with your specific requirements. All the customized samples will be provided as per the requirement with the real data masked.
All our reports are available in Digital PDF format. In case if you require them in any other formats, such as PPT, Excel etc you can submit a request through “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
We offer a free 15% customization with every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
We have 3 different licensing options available in electronic format.
- Single User Licence: Allows one person, typically the buyer, to have access to the ordered product. The ordered product cannot be distributed to anyone else.
- 2-5 User Licence: Allows the ordered product to be shared among a maximum of 5 people within your organisation.
- Corporate License: Allows the product to be shared among all employees of your organisation regardless of their geographical location.
All our reports are typically be emailed to you as an attachment.
To order any available report you need to register on our website. The payment can be made either through CCAvenue or PayPal payments gateways which accept all international cards.
We extend our support to 6 months post sale. A post sale customization is also provided to cover your unmet needs in the report.
Request Customization
We provide a free 15% customization on every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
Note: This customization is absolutely free until it falls under the 15% bracket. If your requirement exceeds this a feasibility check will be performed. Post that, a quote will be provided along with the timelines.
WHY CHOOSE US ?
Assured Quality
Best in class reports with high standard of research integrity
24X7 Research Support
Continuous support to ensure the best customer experience.
Free Customization
Adding more values to your product of interest.
Safe & Secure Access
Providing a secured environment for all online transactions.
Trusted by 600+ Brands
Serving the most reputed brands across the world.
